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ABSTRACT  Mouse  monoclonal  antibody,  S-30, was  produced  from  hybridoma  preparation 
from mice injected with the cytoskeleton extract of an in vitro aged culture of human fibroblasts 
derived from a 66-yr-old donor. The antibody stains positively the nuclei of the nonproliferating 
cells present predominantly  in the senescent cultures of five selected fibroblast strains derived 
from donors of different age groups, whereas a negative reaction is observed in the cultures 
of their young counterparts.  In the intermediate  stage of the in vitro life span of these cell 
strains,  a  heterogeneous  positive  reaction  for  staining with  S-30 antibody is  observed in 
different subfractions of cell cultures. However, the expression of S-30 can be induced in the 
young fibroblasts at the early stage of their life  by prolonged  culturing  to confluence.  This 
induced  expression of S-30 nuclear staining can be depleted  upon subculturing  at low cell 
density. Immunoelectron  microscopy with colloidal gold-protein A complex demonstrates that 
the S-30 proteins are present in the nuclear plasma and at the region of nuclear envelope in 
a clustered arrangement. Immunoprecipitation  of [3H]leucine  labeled cell specimens shows 
that the antibody S-30 reacts with a protein with a molecular weight of -57,000. 
Cultures of normal human fibroblasts have a finite life span 
in vitro. This restriction on proliferating capacity has been 
interpreted as a  manifestation of senescence at the cellular 
level (1, 2). Initially, the cultures proliferate vigorously. How- 
ever,  with  successive  subeultivation,  the  growth  rate  of a 
culture  progressively declines  and  ultimately  falls  precipi- 
tously. Cristofalo and Sharf (3)  have shown that a  progres- 
sively decreasing fraction of the cells in a population synthe- 
sizes DNA,  as the population approaches the end of its in 
vitro life. Senescent fibroblasts that have ceased to proliferate 
are halted  in  the GI  phase of the cell cycle (4).  Thus,  for 
human fibroblasts, an inability to begin DNA synthesis is a 
hallmark of cellular senescence. 
Although  the  cessation  of replication  can be interpreted 
according to either concept, i.e.,  cellular senescence vs. ter- 
minal  differentiation,  a  common  basis  exists  in  that  the 
expression  of a  new  set  of genes,  governing the  cell cycle 
traverse at the G0/G 1 phase of the cell cycle, appears to be 
needed  for the  cessation  of proliferation  to  occur.  Recent 
studies of heterokaryons produced by fusion between virus- 
transformed cells and senescent cultures support this hypoth- 
esis and suggest further that the expression of these genes is 
dominant (5-8). Therefore, near the end of the fibroblasts' in 
vitro life span, molecular events occur that lead to the pro- 
duction of proteins that may express the cellular commitment 
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to leaving the process of cell cycling. The senescent phenotype 
may then represent a consequence of these events. 
As an approach to the search  for the  senescence-specific 
expression of unique proteins, I report here the identification 
and characterization of a monoclonal antibody that can rec- 
ognize a protein of 57,000 mol wt in the nuclei of nonprolif- 
erating  fibroblasts in  aged cultures  but  not  in  the  rapidly 
dividing cells of their young counterparts. 
MATERIALS AND  METHODS 
Cell Strains:  I have used five cell strains, derived from human donors 
of different ages, to generate fibroblastic cultures at various stages of their in 
vitro life span. The cell strains received from the Human Genetic Cell Reposi- 
tory  (Camden,  N J)  were  initially incubated  in  Eagle's minimum essential 
medium supplemented with 10% fetal calf serum and 1% nonessential amino 
acid. As soon as cell cultures became confluent, a strict schedule of subeulti- 
vation was followed as described (9). In brief, the in vitro life history of a given 
cell strain can be defined by recording the number of population doublings per 
passage and the time involved, and the cumulative number of actual population 
doublings (CPDLs) ~  during passage to the end of the proliferative life span of a 
culture. The CPDL for each of the five cell strains is listed in Table I. 
Preparation of Immunogens:  Approximately  l  x  l0  s  cells of 
Abbreviation used in this paper: CPDL, cumulative number of actual 
population doublings. 
545 FIGURE  1  The expression of a senescence-specific protein (SSP),  S-30,  in young and old fibroblast cultures of two different cell 
strains, by  phase-contrast (a, c,  e, and g) and  immunofluorescence (b,  d, f, and h)  microscopy. (a and b) Lack of S-30  staining 
activity in the nuclei of 001 i  fibroblasts at early stage of their life span (CPDL <  10). (c and d) The positive staining reaction of S- 
30 antigen in senescent fibroblasts of the 0011  cell strain (CPDL >  65). Approximately 95% of the cell population at this stage 
demonstrates the positive nuclear staining pattern shown here. (e and/) Lack of S-30 staining in young cells of 3529 strain (CPDL 
<  10). (g and h) Positive staining reaction of S-30  in senescent fibroblasts of the 3529 cell strain (CPDL >  30). Again, the staining 
reaction was found in ~98% of the cell cultures, x  600. 
nonproliferating senescent cultures of fibroblast strain 3529 (donor age, 66 yr) 
at CPDL  >  30 were used as the starting material. Cells at this stage of life do 
not show any proliferative activity.  These cells were then processed for extrac- 
tion of cytoskeleton fraction as described (10).  The cytoskeletal  fraction was 
then separated into aliquots of protein concentrations (5 mg/ml) and injected 
as antigens into mice as described (11). 
Production and Screening  of  Mouse  Hybridoma:  Mouse 
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hybridoma was prepared according to a modification of  the procedure originally 
described by Kohler and Milstein (11,  12). The hybridoma fluid was screened 
against cells derived from both young (001 I, 8 fetal wk) and old (3529,  66 yr) 
donors at early,  intermediate and late CPDLs. The screening was performed 
directly on formaldehyde-fixext  and acetone-extracted cells grown on multiwell 
microscopic slides as described (13). 
Immunofluorescence  Microscopy:  Cell  specimens  stained  for monoclonal  antibodies  were prepared  in a way similar to the procedure  de- 
scribed for polyclonal antibodies  (14), except that the primary antibody  was 
incubated  for 12-16  h at 37°C, to ensure binding  between immunoglobulin 
molecules and the cytoskeletal proteins. The second antiserum used for staining 
monoclonal  antibodies  was fluorescent goat antimouse immunoglobulin,  di- 
rected toward IgG and IgM molecules. Goat antimousc IgG was purchased 
from Cappel Laboratories (Cochranville, PA) or from Antibodies Inc. (Davis, 
CA). These  secondary  antisera  were absorbed  with  formaldehyde-fixed and 
acetone-extracted cell specimens before use in order to remove the nonspecific 
background reaction. The concentration  of  goat immunoglobulin  used for each 
staining reaction was standardized to 0.04 mg/ml. Visualization of  the prepared 
specimens  was performed  with  a  Zeiss photomicroscope  lIl equipped  with 
epifluorescence illumination  and a  63x optic  (Carl Zciss, Inc., Thornwood, 
NY). The specimens were photographed at ASA 800 with Kodak Tri-X film. 
Indirect Immunoelectron Microscopy:  Colloidal gold particles, 
~5 nm in diameter,  were prepared  according to the procedure  described by 
Faulk and Taylor (15). These particles were conjugated with protein A (Sigma 
Chemical Co., St. Louis, MO), and used as described (13). I used an added step 
of  incubation with rabbit antimouse IgG + IgM after the initial staining reaction 
with the primary monoclonal  antibody,  before reaction  with gold-protein  A 
complex. 
Immunoprecipitation:  Cell  cultures were washed in leucine-free me- 
dium and incubated  in this medium at 37"C for 15 min before the addition of 
[3H]leucine (100-200  #Ci/ml,  750-1,000  #Ci/mmol; New England  Nuclear, 
Boston, MA). Cells were labeled for l0 h in ~5 ml of medium per 100-mm 
petri dish. Labeled protein fractions were immunoprecipitated  by modification 
of the protein-A method of Kessler (16). In brief, 2 #l of antiserum  was mixed 
with  l0 ~tl of the labeled extract, which had been adjusted to 0.1% SDS and 
0,5% Nonidet-P40 (NP40). The mixture was incubated at 4°C overnight. Rabbit 
antimouse IgG was added to the mixture at a concentration  of 0.04 mg/ml and 
incubated  at 4" for 2 h. Antigen-antibody  complexes were then precipitated 
with 40 ~l of a  I:10 (vol/vol)  suspension of protein-A  Sepharose beads. The 
precipitate was washed three times with 1% NP40,  l0 mM Tris-HC1 (pH 8.0), 
and three times with  10 mM Tris-HCl (pH 8.0), as described by Kruegar et al. 
(17). The washed immunoprecipitates  were then boiled for 5 rain in 0.06 M 
Tris-HCl, 2% SDS, 10% glycerol, and 5% B-mercaptoethanol, and centrifuged 
to remove  the beads. The supernatant was analyzed  by electrophoresis and 
autoradiography as described (14). 
Quantitation of Growth State:  The  status  of cell growth  was 
examined by long-term serial culturing to assess population  doubling levels as 
described in detail  by Wang and Gundersen 08) and shown in Table  I. In 
addition, the proliferating potential was measured by thymidine  incorporation 
for assay of the activity  of DNA synthesis, as described  by Hollenberg and 
Cuatrecasas (19). In brief, cultures  were labeled with  5 ml growth  medium 
containing  1 #Ci/ml of (methyl-3H) thymidine.  The labeling was carded  out 
for 16 h and the reaction was stopped by rinsing with cold phosphate buffered 
saline (4°C). The cells were treated with 5% trichloroacetic acid and extracted 
with methanol. The cell monolayer was hydrolyzed at 70°C for 15 min in 2 ml 
0.2 N NaOH. After neutralization  with 2 ml of 0.2 N HCI, l ml aliquot of the 
labeled cell material was added to l0 ml scintillation fluid and counted. 
RESULTS 
Results of immunofluorescence microscopy show that  S-30 
antigen is localized in the nucleus of in vitro aged fibroblasts 
derived  from both  young and  old  donors  (Fig.  1).  In  cell 
cultures derived from a donor of 8 fetal wk, the absence of S- 
30  related  nuclear  staining  was  observed in  ~98%  of the 
fibroblast population at the early stage of in vitro life span, 
with CPDL <  10 (Table I and Fig.  l, a  and b). In contrast, 
the distinct nuclear staining of S-30 antibody was found in 
98% of the cells of the same cell strain at a late stage of their 
in vitro life span, with CPDL >  65 (Fig.  1, c and d). Similar 
FIGURE  2  The heterogeneous expression of a senescence-specific protein (SSP), S-30,  in cultures at the intermediate stage of 
their life span by phase-contrast (a and c) and immunofluorescence (b and d) microscopy. (a and b) Staining pattern of S-30  in 
the  0011  cell  strain  at  CPDL  =  40.  Approximately 30-40%  of the  cell  population  shows S-30  staining activity,  whereas the 
remaining subfraction of the cell culture is still negative (arrows). (c and d) Staining pattern of S-30 in the 3529 cell strain at CPDL 
=  15.  Approximately  20-30%  of, the  cell  population  shows  the  positive  reaction  with  S-30  antibody,  whereas the  remain 
subfraction is negative (arrows). x  600. 
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The Presence  of S-30 Staining Pattern in Five Selected Strains of Fibroblasts 
Donor  CPDL 
Earliest avail- 
Repository number  Age  Sex  able PDLs  Mean  Range 
GM0011  8 fetal wk  M  6  65  57-72 
GM2936B  20 d  M  16  57  54-60 
GM0038A  9 yr  F  21  56  52-61 
GM2912A  26 yr  M  5  31  27-38 
GM3529  66 yr  M  3  28  24-32 
PDLs to show S-30 staining 
pattern 
(-)*  (+I-)*  (+)~ 
6-15  15-55  >65 
--  16-53  >53 
--  21-52  >52 
5-10  10-30  >30 
3-10  10-27  >27 
PDLs, population doubling levels. 
* Approximately 80-95% of cell population shows negative staining reaction for S-30 antibody. 
* The percentage of cell population showing positive reaction for S-30 antigens varies in different CPDLs. 
i Approximately 90-95% of cell population shows positive reaction for S-30 antibody. 
TABLE  II 
Comparison between S-30 Staining and Activity of DNA Synthesis 
0011  3529 
S-30  S-30 
Repository number  CPDLs  cpm  staining  CPDLs  cpm  staining 
Young cells  <10  16,894 +  250  -  <10  15,951  _  360  - 
Senescent cells  >65  4,206 _.+ 150  +  >30  3,052 _  105  + 
FIGURE  3  S-30  expression in  young fibroblasts of confluent  cul- 
tures.  Cultures  of 0011  at  CPDL  <  10  were  allowed to  grow to 
confluence and remain at this high cell density for a week before 
processing for  immunoflurorescence  microscopy  with  S-30  anti- 
body. (a and b) Phase and fluorescence microscopy of S-30 staining 
pattern.  In  some  cells  (arrow),  the  expression  of  S-30  is  quite 
prominent, x  600. 
absence of S-30 staining in most young fibroblasts (CPDL < 
10) and its presence in 98% of  the senescent fibroblasts (CPDL 
>  30) was observed in the 3529 cell strain, derived from a 66- 
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yr-old donor (Fig.  1, e-h). 
S-30  staining  was  examined  more  closely  with  various 
cultures of human  fibroblasts at the  intermediate stages of 
their in  vitro replicative life span.  Fig.  2  demonstrates that 
the presence of  S-30 in these cultures is heterogeneous, ranging 
from abundant,  as evidenced by brightly stained  nuclei,  to 
scarce, as evidenced by the lightly stained nuclear envelope, 
to absence of staining in -60% of the cells in cultures. The 
faint staining of S-30 at the region of the nuclear envelope 
may indicate that S-30, when it is expressed initially, is located 
at the outskirts of nuclei, but that once it becomes abundant, 
it  extends  its  expression  throughout  the  nucleoplasm  and 
nucleoli. 
The nuclear staining pattern of S-30 antibody was found in 
the nonproliferating senescent fibroblasts of  all five cell strains 
(Table I). In contrast, the absence of S-30 staining was found 
in cultures of their young counterparts, whereas the hetero- 
geneous  presence  of nuclear  staining  was  observed  in  the 
intermediate period of their life span. 
The growth state of various cultures used for the immuno- 
fluorescence studies as shown in  Fig.  1 was assessed by the 
incorporation  of [3H]thymidine.  Thymidine  incorporation 
was measured as described in Materials and Methods. Parallel 
cultures of those cells used in Fig.  1 were quantitated for the 
activity  of  DNA  synthesis  by  16  h  of  incorporation  of 
[3H]thymidine. Monolayer cultures of both young and senes- 
cent cells were harvested at the similar sparse density of 3,550 
cells/cm  2. The mean __. SD values of three determinations are 
expressed as counts per minute  of cell-bound radioactivity 
(Table II). 
As illustrated here, cultures of 0011  cell strain showing the 
predominant presence of S-30 staining have only one-quarter 
of the level of activity of DNA synthesis of those showing the 
absence of staining  activity.  A  similar  reverse  relationship 
between the activity of DNA synthesis and the presence of S- 
30 staining was also observed in cell strain 3529, derived from 
the 66-yr-old donor. FIGURE  4  Immunogold localization of  S- 
30  antigen  in  senescent fibroblasts (0011 
at CPDL  >  65).  The  antigen-antibody re- 
action  in  situ  was  visualized  by  further 
incubation with  rabbit antimouse IgG fol- 
lowed by protein-A conjugated with 5-nm 
gold particles. As illustrated in (A), most of 
the  gold  particles are  located  in  the  nu- 
cleus (N), with a significant number of gold 
particles concentrated  at the  nuclear en- 
velope region. (A) x  80,000; (B) x  150,000. 
The expression of S-30 can be induced in fibroblasts at the 
early stage of their in vitro life span by arrest of proliferation, 
such as by contact inhibition of growth and serum starvation. 
For examp  el'~,  the bright staining pattern of S-30 antibody was 
observed in the nuclei of young fibroblasts (CPDL =  10; 001 l 
cell strain) grown to a density of 35,500 cells/cm  2 (Fig. 3). As 
examined by time-lapse cinematography, the mitotic index at 
this culturing density is -2%. The S-30 staining remained in 
these cells after trypsinization and replating of the confluent 
cultures. The absence of S-30 was not observed until after the 
first mitosis in the replated cultures. 
The specific cellular location of S-30 antigens was identified 
by indirect immunoelectron microscopy. S-30 antigens were 
concentrated in the nucleus as shown by immunofluorescence 
microscopy (Fig.  4).  In  some  instance,  the  S-30  staining 
pattern was observed as patches of clustered gold particles at 
the nuclear envelope region, with strands of gold decorated 
strings extending into the interior of the nucleus (Fig. 4). 
Biochemical identification of the antigens reacting with S- 
30  antibody  was  performed  with  immunoprecipitation  of 
[3H]leucine  labeled  cell  materials.  As  shown  in  Fig.  5,  a 
distinct band located at -57,000  mol wt was observed with 
the  precipitable materials from senescent  cultures  of 0011 
flbroblasts (CPDL  =  60;  lanes  8  and  9)  and  in  confluent 
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=  35,500  cells/cm2; lanes 5  and  6).  Trace amounts of the 
57,000-mol-wt protein also were observed in cultures at the 
early stage of 0011  fibroblast life span (CPDL =  10; lanes 2 
and  3).  Control  experiments  showed  an  absence  of S-30 
related antigens when the initial incubation was replaced with 
the hybridoma growth medium (lanes 4 and  7). In all lanes 
showing  the  precipitable  bands  of 57,000  mol  wt,  several 
bands at higher molecular weight were also observed, indicat- 
ing the possibility of a precursor for this S-30 related protein 
or contaminants during the process of immunoprecipitation. 
Pulse-chase experiments are  being performed to  verify the 
existence of the precursors for S-30 related antigens. 
DISCUSSION 
I have demonstrated a protein of ~57,000 mol wt (p57) to be 
present in nonproliferating fibroblasts that have been aged by 
in  vitro serial  passage but  absent  in  their  rapidly growing 
young counterparts. The protein is located in the nucleus of 
these nonreplicating aged cells.  However, the expression of 
this  57,000-mol-wt  protein,  recognized by the  monoclonal 
antibody S-30, can be induced in young fibroblasts by means 
of several culturing techniques that arrest cell growth, such as 
contact inhibition  of proliferation in  dense monolayer cul- 
tures. In a broader sense, the presence of p57 polypeptide can 
be used to differentiate nonreplicating cells from their repli- 
cating counterparts.  Since  senescent fibroblasts are defined 
conventionally by the advent of cessation of replication, S-30 
antibody can therefore be used as a marker for in vitro cellular 
aging. 
From the initial experiments with immunogold labeling, I 
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FiGUrE  5  Immunoprecipitation with  the 
S-30  monoclonal antibody.  The  detail  is 
included  in  Materials  and  Methods. 
Whole cell homogenates derived from fi- 
broblasts at different stages of their in vitro 
life  span  were  used  as  the  substrate  for 
the  immunoprecipitation  assays.  Lane  1, 
Molecular  weight  standards;  band  A 
(94,000);  band  B  (68,000);  band  C 
(43,000).  Lanes 2  3  show absence of any 
obvious  precipitable  bands  when  the 
0011  fibroblasts at CPDL =  10 with a cell 
density of  3,550  cells/cm  2 were  used  as 
the substrate. Lane 4, specimens from the 
same cell culture were reacted with con- 
trol  medium  in  place  of  the  hybridoma 
fluid.  Lanes 5-6  show the  presence of a 
protein band at 57,000 mol wt (arrow) as 
well  as  the  high  molecular  weight  band 
(double arrow) when the 0011  fibroblasts 
at  CPDL  =  10  were  grown  to  high  cell 
density  at  35,500  cells/cm  2.  Lanes  8-9 
show  the  similar  pattern  of  precipitable 
bands at 57,000  mol wt and  high  molec- 
ular  weight  region  when  the  senescent 
0011  fibroblasts  (CPDL  =  60} were  used 
as  the  substrate.  Three  times  more  sub- 
strate was used for the immunoprecipita- 
tion assays  in lanes 5 and 8  than those in 
lanes 6  and 9.  Lane 7 shows the absence  • 
of  precipitable  bands  when  the  hybrid- 
oma  medium  was  used  in  place  of  the 
primary hybridoma fluids. 
cannot speculate whether the p57 polypeptides are localized 
exclusively in  the  matrix  component  of the  nucleus.  The 
harsh treatment of extraction by detergent during the prepar- 
ative steps for either immunofluorescence or immunoelectron 
microscopy limits our localization of  the S-30 related antigens 
to  the  insoluble  scaffold.  Therefore,  my conclusion  so  far 
suggests  that  p57  becomes associated  specifically with  the 
nonextractable matrix of the nucleus.  Results of future bio- 
chemical experiments will reveal to us whether the protein is 
also present in the soluble fraction of the nucleus in senescent 
cells. 
Preliminary  experiments  with  human  skin  biopsy  have 
revealed the presence of S-30 related antigens in the nuclei of 
nondividing terminally differentiated keratinocytes but not in 
dividing cells located at the basal layer close to the dermis 
(data not shown). These results demonstrate that markers for 
senescence need not be restricted to studies of fibroblast aging; 
they are also useful in studies of other differentiation processes 
of many types of stem cells,  when a  common denominator, 
cessation of  replication, acts as the key signal for advancement 
into the terminal stage of development. The ready applicabil- 
ity of such markers in  neoplasm is obvious when their ab- 
sence, associated with transformation-related cell growth, oc- 
curs in tissues destined physiologically to be nonproliferative. 
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